# Reasoning trace

## Question and resolved ambiguities

The requested readout is the integer number of measured genes with BH-adjusted
Wilcoxon `pvals_adj < 0.05` after loss of each held-out perturbation in
`151 TH Prkcd Grin2c Glut` nuclei. The count is over the differential-expression
rows for that target/cell-type pair and can include the perturbed target's own
transcript if that transcript was measured and passed FDR. The task is not to
estimate editing, cell survival, or target importance.

This run contains exactly one held-out target, `Atp6ap1`. I confirmed that it is
absent from both supplied training inputs, so every numerical comparison below
uses only non-held-out targets.

## Sources

Internal same-experiment sources:

- Differential-expression parquet:
  `[local file: training_de_all_cell_groups.parquet]`
- Focal-cell training DEG counts:
  `[local file: 151_TH_Prkcd_Grin2c_Glut_deg_counts_training.csv]`
- Requested-target manifest:
  `[local file: 020_Atp6ap1.csv]`
- Distributed Agents same-experiment corpus
  `perturbai-july-260713-sourceguard-1773-v1`. `Atp6ap1` itself had no
  retrieved target context in this held-out corpus, but V-ATPase relatives did:
  the corpus claim most relevant here states that represented V-ATPase subunits,
  accessory factors, and lysosomal neighbors were sparse, divergent, or flat
  rather than a shared postnatal neuronal snRNA-seq module.
- Distributed Agents runtime profile comparison over the focal-cell log-fold-change
  surfaces of `Atp6ap2`, `Atp6v0a1`, `Atp6v1a`, `Atp6v1b2`, `Atp6v1e1`,
  `Rab7`, `Rb1cc1`, and `Tsc2`.

External biological sources:

- Jansen and Martens 2012, DOI `10.2174/138920312800493160`: review of the
  V-ATPase accessory proteins ATP6AP1/Ac45 and ATP6AP2/(pro)renin receptor and
  their roles in neuroendocrine secretory V-ATPase regulation.
- Abbas et al. 2020, DOI `10.1126/science.aaz2924`: cryo-EM structure of
  mammalian brain V-ATPase placing cleaved ATP6AP1/Ac45 and ATP6AP2/PRR in the
  membrane V0 sector and describing their participation in assembly of the
  catalytic and membrane regions.
- Rujano et al. 2017, DOI `10.1084/jem.20170453`: ATP6AP2 disease mutations
  impair ATP6AP1 interaction and V-ATPase assembly, producing glycosylation and
  autophagy defects.
- Ma et al. 2022, DOI `10.1038/s41586-022-04431-8`: metformin-bound PEN2 forms
  a complex with ATP6AP1 on lysosomal V-ATPase to engage AMPK signaling.
- Feng et al. 2024, DOI `10.1038/s41422-024-00938-z`: ATP6AP1 can interact with
  Rheb in cancer-cell models and promote Rheb/mTORC1 activation; I used this
  only as a weak mechanistic prior because the system is far from postmitotic
  thalamic neurons.

## Computations over the training data

I loaded the focal training-count CSV and summarized the response scale. Among
1,674 non-held-out targets, 1,205 had zero DEGs, 363 had 1-9 DEGs, 63 had
10-99 DEGs, and 43 had at least 100 DEGs. The distribution is therefore strongly
concentrated at zero, with the "weak" 1-9 DEG class as the common nonzero
alternative.

For mechanistic analogs, I filtered the parquet to
`group_name == "151 TH Prkcd Grin2c Glut"` and counted rows with
`pvals_adj < 0.05` for V-ATPase, endomembrane-acidification, lysosomal, and
mTOR/autophagy-related training perturbations. The core query was:

```sql
SELECT gene_target,
       SUM(CASE WHEN pvals_adj < 0.05 THEN 1 ELSE 0 END) AS n_sig,
       SUM(CASE WHEN pvals_adj < 0.05 AND logfoldchanges > 0 THEN 1 ELSE 0 END) AS n_up,
       SUM(CASE WHEN pvals_adj < 0.05 AND logfoldchanges < 0 THEN 1 ELSE 0 END) AS n_down
FROM training_de
WHERE group_name = '151 TH Prkcd Grin2c Glut'
  AND gene_target IN (...)
GROUP BY gene_target;
```

The focal counts for the most relevant training targets were:

| training target | observed `n_degs` in 151 | focal FDR-significant genes |
|---|---:|---|
| `Atp6ap2` | 2 | `Atp6ap2` down, `Atp6v0a1` down |
| `Atp6v0a1` | 1 | `Atp6v0a1` down |
| `Atp6v1a` | 0 | none |
| `Atp6v1b2` | 0 | none |
| `Atp6v1e1` | 0 | none |
| `Mtor` | 2 | small loss-of-function mTOR response |
| `Rptor` | 0 | none |
| `Tsc2` | 86 | medium mTORC1/SREBP-like counterexample |
| `Rab7` | 501 | broad late-endosomal/lysosomal counterexample |
| `Rb1cc1` | 4 | weak autophagy-initiation/ER-chaperone response |
| `Atg5`, `Becn1`, `Atg16l1` | 0 | none |
| `Gnptab`, `Manba`, `Sort1`, `Lamp2` | 0 | none |
| `Gaa`, `Ppt1`, `Psap`, `Tmem106b` | 1 each | target self transcript only |
| `Clcn3`, `Slc9a9` | 0 | none |
| `Clcn4`, `Slc9a7` | 1 each | target self transcript only |
| `Cltc` | 3 | small trafficking response |

I also ran a focal-cell profile comparison among the main V-ATPase analogs plus
`Rab7`, `Rb1cc1`, and `Tsc2`. The close V-ATPase set had no shared
FDR-significant genes, and Distributed Agents corpus findings for `Atp6ap2`,
`Atp6v0a1`, `Atp6v1a`, and `Atp6v1e1` independently annotated the same point:
same-pump membership was not enough to create a common BH-significant
transcriptional state. Full logFC-vector correlations among these nearly flat
profiles were not decisive because they came from low-information tails, not
from exact significant feature overlap.

## Target-specific prediction

### `Atp6ap1`

ATP6AP1/Ac45 is a membrane V0-sector accessory protein of the V-ATPase, and
brain V-ATPase structures include both ATP6AP1 and ATP6AP2/PRR in the membrane
sector (Jansen and Martens 2012; Abbas et al. 2020). ATP6AP2 is the most direct
assayed accessory-protein analog: ATP6AP2 deficiency can impair its interaction
with ATP6AP1 and V-ATPase assembly (Rujano et al. 2017). In the focal
training data, however, `Atp6ap2` had only two significant rows, its own
transcript and a modest `Atp6v0a1` decrease. Direct perturbation of the
neuronal V0 a1 subunit `Atp6v0a1` had only the self transcript, and direct
perturbations of `Atp6v1a`, `Atp6v1b2`, and `Atp6v1e1` had no FDR<0.05 genes in
this same focal group.

Those close measurements argue against a broad nuclear response to acute
`Atp6ap1` loss. The V-ATPase and acidification comparisons also argue against
borrowing from generic lysosomal-disease perturbations: `Gaa`, `Ppt1`, `Psap`,
`Ctsb`, `Tmem106b`, `Clcn4`, and `Slc9a7` were one-gene self hits or similarly
tiny in 151, while `Gnptab`, `Manba`, `Lamp2`, `Sort1`, `Clcn3`, and `Slc9a9`
were zero. `Rab7` is an important counterexample because it proves that the
focal thalamic neurons can show a large endolysosomal/lysosomal compensation
program; its 501 DEGs did not make the V-ATPase subunit/accessory perturbations
large. `Tsc2` is another counterexample: its 86-DEG mTORC1/SREBP output shows
that growth/lysosome-adjacent RNA responses can be detected, but loss of
positive mTORC1 components was tiny (`Mtor`, 2; `Rptor`, 0). Therefore the
ATP6AP1-Rheb or PEN2-AMPK literature raises a pathway possibility, not enough
evidence to move `Atp6ap1` into the medium-count range.

I predict a weak nonzero endpoint rather than an exact zero for two reasons.
First, `Atp6ap1` itself is present in the measured feature set, and the nearest
accessory analog `Atp6ap2` passed FDR for its own transcript in this cell group.
Second, the Atp6ap2 mini-signature suggests that an accessory-protein lesion
can produce at least one direct V-ATPase-axis RNA change without activating a
full lysosome or UPR module. I do not see evidence for more than one or two
genes, though: the represented core pump subunits sit at 0-1 DEG in the focal
data, and the Distributed Agents corpus explicitly warns that their measured responses
are subunit-specific, sparse, and non-phenocopying.

Point prediction: `1` DEG.

## Limits of the reasoning

The main limitation is that no held-out `Atp6ap1` signature, indel data,
V-ATPase protein measurement, organelle-pH readout, autophagic-flux assay, or
abundance/survival endpoint is available. If edited `Atp6ap1`-null neurons were
selectively lost before P37-44, the recovered nuclei could look deceptively
quiet. Conversely, ATP6AP1 could disrupt vesicle acidification or mTOR/AMPK
signaling post-translationally without crossing a nuclear snRNA FDR threshold.
The closest analog `Atp6ap2` is mechanistically close but not interchangeable:
it is also PRR and Wnt-adaptor biology, while ATP6AP1/Ac45 has its own
secretory-pathway functions. The exact count is therefore an extrapolation from
tiny V-ATPase accessory/core responses, with uncertainty between 0 and 2; I
chose 1 as the most conservative weak nonzero count.
